RE: 're mms20 Nov 2018 11:39
Morning Charty
Just a quick look in.
Technically speaking, how do you value a company only one untested drug no revenue and 100% failure rate ?
Market sentiment is poor atm. The high risk takers have plenty of choice out there and unless genuine quality news is released (which can't happen anytime soon) it's just down to traders to play with.
Bom dia.